FDA Grants AP Status for Methotrexate Sodium ANDA213362
The FDA has granted approval status (AP) for the ANDA213362 application for Methotrexate Sodium submitted by Daito.
Asset / Drug
Drug and asset intelligence for Daito with 2 indexed intelligence signals across regulatory, clinical, competitive, and market developments.
Chemotherapy
No catalysts indexed for this entity yet.
No related entities indexed yet.
Newsletter
Concise strategic intelligence on regulatory, clinical, competitive, and market developments — free to subscribe.
No paywall. No spam. Unsubscribe anytime.